Michael Pickel - Hannover Member of the Executive Board
| HVRRY Stock | USD 44.55 0.24 0.54% |
Executive
Dr. Michael Pickel is Member of the Executive Board at Hannover Rueck SE since 2002. He is responsible for Group Legal Services, Compliance, RunOff Solutions as well as Target Markets in Property and Casualty Reinsurance, comprising the regions North America and Continental Europe at the Company. He previously worked for the Gerling Group, where he held the positions Head of the Legal Department and Claims Management and Head of Treaty Reinsurance for Europe and South America. Dr. Pickel also held positions at Gerling Globale Rueck in Milan, Italy. Dr. Pickel studied Law at Universitaet zu Koeln. since 2002.
| Age | 63 |
| Tenure | 22 years |
| Phone | 49 511 5604 0 |
| Web | https://www.hannover-re.com |
Hannover Management Efficiency
The company has return on total asset (ROA) of 0.0148 % which means that it generated a profit of $0.0148 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.128 %, meaning that it generated $0.128 on every $100 dollars invested by stockholders. Hannover's management efficiency ratios could be used to measure how well Hannover manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Finbar Griffin | Greenlight Capital Re | N/A | |
| Linda Lin | Siriuspoint | N/A | |
| Nicholas Campbell | Siriuspoint | 55 | |
| Blythe Walker | Renaissancere Holdings | N/A | |
| Jesus Spinola | Reinsurance Group of | N/A | |
| Raymond Kleeman | Reinsurance Group of | 51 | |
| Mark Brooks | Reinsurance Group of | 54 | |
| Tracey Gibbons | Siriuspoint | N/A | |
| Nicole Valadao | Renaissancere Holdings | N/A | |
| Hugh Brennan | Renaissancere Holdings | 47 | |
| Bryan Dalton | Renaissancere Holdings | N/A | |
| Stephen Yendall | Siriuspoint | 49 | |
| Sean CFA | Renaissancere Holdings | 48 | |
| Anthony LeHan | Siriuspoint | 63 | |
| Becket McNab | Renaissancere Holdings | N/A | |
| Justin Brenden | Siriuspoint | 40 | |
| JeanPierre Cormier | Reinsurance Group of | N/A | |
| Adam Prior | Greenlight Capital Re | N/A | |
| Mark Heintzman | Maiden Holdings | 64 | |
| James McKinney | Siriuspoint | 44 | |
| Robin Lang | Renaissancere Holdings | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0148 |
Hannover Re Leadership Team
Elected by the shareholders, the Hannover's board of directors comprises two types of representatives: Hannover inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hannover. The board's role is to monitor Hannover's management team and ensure that shareholders' interests are well served. Hannover's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hannover's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Clemens Jungsthofel, CFO Board | ||
| Sven Althoff, Member of the Executive Board | ||
| Michael Pickel, Member of the Executive Board | ||
| Klaus Miller, Member of the Executive Board | ||
| Karl Steinle, General Manager Corporate Communications | ||
| Julia Hartmann, Senior Investor Relations Manager | ||
| JeanJacques Henchoz, CEO Board | ||
| Michael Eberhardt, Managing Branch | ||
| Claude Chvre, Member Board | ||
| Silke Sehm, Member Board |
Hannover Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Hannover a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0148 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 26.82 B | |||
| Shares Outstanding | 241.19 M | |||
| Price To Earning | 21.25 X | |||
| Price To Book | 2.76 X | |||
| Price To Sales | 0.77 X | |||
| Revenue | 26.15 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hannover Pink Sheet Analysis
When running Hannover's price analysis, check to measure Hannover's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hannover is operating at the current time. Most of Hannover's value examination focuses on studying past and present price action to predict the probability of Hannover's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hannover's price. Additionally, you may evaluate how the addition of Hannover to your portfolios can decrease your overall portfolio volatility.